Hoth Therapeutics, Inc.
HOTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $15 | $0 | $5 |
| - Cash | $8 | $9 | $11 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $6 | -$11 | -$2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$2 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$2 | -$3 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.3 | -0.17 | -0.36 | -0.33 |
| % Growth | -76.5% | 52.8% | -9.1% | – |
| Operating Cash Flow | -$2 | -$2 | -$3 | -$2 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$3 | -$2 |